Effect of budesonide and salbutamol on serum IL-6 and TNF- levels in bronchopneumonia
10.3969/j.issn.1005-1678.2017.01.056
- VernacularTitle:布地奈德与沙丁胺醇对支气管肺炎患者血清IL-6、TNF-α的影响
- Author:
Huanhuan YANG
;
Ningning YU
- Keywords:
budesonide;
salbutamol;
bronchopneumonia;
interleukin -6;
tumor necrosis factor alpha
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):191-193
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the therapeutic effect of budesonide combined with salbutamol on serum interleukin (IL-6) and tumor necrosis factorα (TNF-α) in treatment of bronchial pneumonia. Methods A total of 110 cases of bronchial pneumonia patients were randomly divided into the study group and the normal group, with 55 cases in each group, the two groups were given oxygen, anti-inflammatory and symptomatic treatment, the study group received budesonide combined with salbutamol treatment, the curative effect and changes of serum IL-6, TNF-alpha levels were compared between two groups. Results The disappeared time of cough, fever, shortness of breath,rhonchi and moist rales, hospitalization time in study group were significantly shorter than the conventional group, the difference was statistically significant (P<0.05). After 5 days' treatment, the serum IL-6, TNF-α in study group were lower than normal group(P<0.05), the PaO2, SaO2 in study group were higher than normal group (P<0.05). The efficacy in study group was higher than normal group (P<0.05). Conclusion Budesonide combined with salbutamol in treatment of bronchial pneumonia patients could improve clinical symptoms and anti-inflammatory effect, so as to shorten the treatment time and improve the clinical effect.